CALIMAN, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 1.915
AS - Asia 1.528
EU - Europa 1.503
SA - Sud America 113
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 31
OC - Oceania 22
Totale 5.173
Nazione #
US - Stati Uniti d'America 1.841
RU - Federazione Russa 530
IT - Italia 510
SG - Singapore 476
CN - Cina 467
HK - Hong Kong 181
KR - Corea 126
VN - Vietnam 102
IE - Irlanda 96
BR - Brasile 91
FR - Francia 61
PL - Polonia 60
DE - Germania 59
FI - Finlandia 54
IN - India 49
CA - Canada 41
SE - Svezia 38
GB - Regno Unito 35
JO - Giordania 27
BD - Bangladesh 26
ID - Indonesia 22
AU - Australia 21
NL - Olanda 16
JP - Giappone 13
NG - Nigeria 11
CH - Svizzera 10
MX - Messico 10
AT - Austria 8
IQ - Iraq 8
ES - Italia 7
EC - Ecuador 6
PK - Pakistan 6
AR - Argentina 5
PH - Filippine 5
UA - Ucraina 5
UZ - Uzbekistan 5
CL - Cile 4
MA - Marocco 4
SV - El Salvador 4
BJ - Benin 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
CZ - Repubblica Ceca 3
EG - Egitto 3
IL - Israele 3
NO - Norvegia 3
PE - Perù 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
CO - Colombia 2
DO - Repubblica Dominicana 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KE - Kenya 2
LT - Lituania 2
TR - Turchia 2
VE - Venezuela 2
ZA - Sudafrica 2
AL - Albania 1
BE - Belgio 1
BH - Bahrain 1
BS - Bahamas 1
BW - Botswana 1
CU - Cuba 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
KZ - Kazakistan 1
LV - Lettonia 1
MY - Malesia 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
PS - Palestinian Territory 1
RO - Romania 1
SA - Arabia Saudita 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 5.112
Città #
Santa Clara 464
Singapore 365
Ashburn 345
Hefei 169
Hong Kong 162
San Jose 154
Seoul 126
Dublin 98
Milan 88
Florence 68
Warsaw 58
Council Bluffs 56
Los Angeles 53
Rome 51
Beijing 50
Chandler 40
The Dalles 37
Helsinki 34
Munich 34
Dallas 33
Buffalo 32
Ho Chi Minh City 29
Paris 29
Boardman 26
Hanoi 25
New York 25
Jakarta 22
Lauterbourg 22
Melbourne 21
Kent 20
Shanghai 18
Moscow 17
Fairfield 16
Mumbai 16
Chicago 15
Bengaluru 12
London 12
Seattle 12
Tokyo 12
Toronto 12
Abuja 11
Boston 11
Houston 11
Naples 11
Phoenix 11
Turku 11
St Louis 10
Altamura 9
Woodbridge 9
Frankfurt am Main 8
Lappeenranta 8
Lawrence 8
Vienna 8
Orem 7
Pune 7
São Paulo 7
Brescia 6
Brooklyn 6
Chennai 6
Genoa 6
Haiphong 6
Palermo 6
Ancona 5
Montreal 5
Verona 5
Acton 4
Bern 4
Bologna 4
Brasília 4
Douglasville 4
Elk Grove Village 4
Figino 4
Guangzhou 4
Lahore 4
Miami 4
Nuremberg 4
Ottawa 4
Ovada 4
Princeton 4
Rio de Janeiro 4
San Francisco 4
Turin 4
Wilmington 4
Yubileyny 4
Zhengzhou 4
Alba 3
Amsterdam 3
Bremen 3
Buenos Aires 3
Charlotte 3
Cotonou 3
Dhaka 3
Duque de Caxias 3
Lecce 3
Macerata 3
Madrid 3
Miano 3
Olomouc 3
Oslo 3
Padua 3
Totale 3.201
Nome #
A case report of eyelid Merkel cell carcinoma occurring under treatment with nivolumab for a lung adenocarcinoma. 297
Ivosidenib in IDH1-mutated cholangiocarcinoma: Clinical evaluation and future directions 281
Gender matters. Sex-related differences in immunotherapy outcome in patients with non-small cell lung cancer 257
Evaluation of Fruquintinib in the Continuum of Care of Patients with Colorectal Cancer 254
Identification of predictive biomarkers of clinical benefits to immunotherapy in pre-treated advanced non-small cell lung cancer: a retrospective observational study 249
Challenges in the treatment of small cell lung cancer in the era of immunotherapy and molecular classification 226
Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy 213
Alteration of the Nucleotide Excision Repair (NER) Pathway in Soft Tissue Sarcoma 204
Evaluation of COVID-19 impact on DELAYing diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario 197
KRAS G12 isoforms exert influence over up-front treatments: A retrospective, multicenter, Italian analysis of the impact of first-line immune checkpoint inhibitors in an NSCLC real-life population 192
In Regard to "Activity of EGFR TKIs in Caucasian Patients With NSCLC Harbouring Potentially Sensitive Uncommon EGFR Mutations" 187
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 186
Chasing the target: New phenomena of resistance to novel selective ret inhibitors in lung cancer. updated evidence and future perspectives 184
Italian survey of second tumors in patients with diagnosis of GIST (gastrointestinal stromal tumor) 183
Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer: An early exploratory analysis of real-world data 182
Immune checkpoint blockade with anti-programmed cell death 1 (PD-1) monoclonal antibody (mAb) cemiplimab: ongoing and future perspectives in rare genital cancers treatment 180
KRAS-related miR-143 expression is associated with lymph node involvement and correlates with outcome in pancreatic adenocarcinoma patients 178
Long-term response of more than 9 years to regorafenib in a heavily pretreated patient with metastatic colorectal cancer 170
Induction chemotherapy followed by pleurectomy decortication and hyperthermic intraoperative chemotherapy (Hithoc) for early-stage epitheliod malignant pleural mesothelioma—a prospective report 169
Prognostic value of normal sodium levels in patients with metastatic renal cell carcinoma receiving tyrosine kinase inhibitors 168
Early changes in circulating tumor DNA (ctDNA) predict treatment response in metastatic KRAS-mutated colorectal cancer (mCRC) patients 146
Safety of Immune Checkpoint Inhibitors in Elderly Patients: An Observational Study 146
Mutations matter: An observational study of the prognostic and predictive value of KRAS mutations in metastatic colorectal cancer 143
Impact of natremia on metastatic non small cell lung cancer patients receiving immune checkpoint inhibitors 141
Liquid Biopsy and Non-small-cell Lung Cancer: Expecting More Fluid Management of Patients 134
The emerging HER2 landscape in colorectal cancer: the key to unveil the future treatment algorithm? 96
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing 95
KRAS G12C inhibition enhances efficacy to conventional chemotherapy in KRAS-mutant NSCLC 67
Th17-like cells and immunosuppressive macrophages infiltrate tertiary lymphoid structures with distinct maturation status in soft-tissue sarcoma 48
Totale 5.173
Categoria #
all - tutte 16.058
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.058


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202225 0 0 1 0 0 2 2 5 0 2 3 10
2022/2023302 7 27 5 29 15 52 45 37 47 13 16 9
2023/2024358 10 14 27 19 24 47 23 77 11 19 35 52
2024/20251.758 63 161 93 274 392 223 53 104 95 58 102 140
2025/20262.318 296 301 307 176 226 73 287 108 146 165 78 155
2026/2027292 92 56 144 0 0 0 0 0 0 0 0 0
Totale 5.173